With the help of Majority Whip, James Clyburn, the House of Representatives approved legislation that would limit cost-sharing for insulin under private health insurance and Medicare. The vote was 232-193, with 12 Republican members joining their Democratic colleagues to pass the measure. The Affordable Insulin Now Act would cap insulin prices at either $35 a month or 25% of an insurance plan’s negotiated price — whichever is lower. The legislation would take effect in 2023, but its fate in the Senate remains unclear.